H1 2024 conference call to be held on August 22, at 8:30 a.m. Eastern Time

HONG KONG, Aug. 15, 2024 /PRNewswire/ — Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, including Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care, and more, today announced that it expects to release its financial results for H1 2024, ended June 30, on Wednesday, August 21, 2024.

Sisram’s management team will host a conference call to discuss the financial results on Thursday, August 22, 2024, at 8:30 a.m. Eastern Time.

Speakers will include Mr. Liu Yi, Sisram’s Chairman, Mr. Lior Dayan, Sisram’s Chief Executive Officer, Mr. Doron Yannai, Alma’s CFO, and Ms. Qianli Fang, Sisram’s VP of IR and Secretary of the Board.  Following the prepared remarks, management will be available for a question-and-answer session.

The conference call can be accessed using the following link: https://s.comein.cn/AHyWW

Alternatively, participants can dial-in with the below numbers, using the passcode: 552254

United States: +1-646-860 9590 China Mainland: +86-400 188 8933Hong Kong S.A.R: +852-5700 6913 Taiwan Region: +886-(0)2-7741 4091Singapore: +65-3158 6120International: +86-010-89632651

The conference call will begin at:8:30 a.m. Eastern Time5:30 a.m. Pacific Time3:30 p.m. Israel Time

A replay will also be available on Sisram Medical’s  IR Events & Presentations page.

About Sisram Medical Ltd

Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, ranging from Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care and more. The company is majority owned by Fosun Pharma, one of China’s leading healthcare groups. On September 19, 2017, Sisram Medical went public on the Main Board of the Hong Kong Exchange.

Sisram Medical – Enhancing Quality of Life

http://www.sisram-medical.com 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

The Moskowitz Law Firm, PLLC Announces Preliminary Approval of a Proposed Class Action Settlement on Behalf of Purchasers of Astrals Non-Fungible Tokens and Galaxy Tokens

MIAMI, Jan. 18, 2025 /PRNewswire/ — The Moskowitz Law Firm, PLLC announces…

ATFX Connect Launches Institutional Edge Q4 2025

A comprehensive source of global market insights for institutional clients and professional…

Eternal Beauty Holdings Releases Fragrance Market Trends White Paper, Showcasing a US$10 Billion Blue Ocean Opportunity

Cross-industry Leaders Unite at the Forum: Pioneering the "New Era of Emotional…